返回
Inhibikase Therapeutics Inc（IKT）价格
IKT 股价走势图
IKT 收益
Inhibikase Therapeutics Inc
$1.67
1.82%
$0.03
收盘价：Feb 13, 16:00:00 GMT-5
$1.65
-1.19%
$-0.02
盘后：Feb 13, 20:00:00 GMT-5
关键数据
前收盘价
$1.64
开盘价
$1.64
当日区间
$1.64 - $1.73
52周范围
$1.33 - $3.32
交易量
218.2K
平均成交量
612.8K
每股收益（TTM）
-1.15
股息收益率
--
市值
$199.4M
什么是 IKT？
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 15 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).